Non-anticoagulant heparins: glycan-mediated immune modulation and therapeutic applications - Top-Institutions - MDSpire

Heparins Without Anticoagulant Properties: Immune Modulation via Glycan Interactions and Clinical Uses

  • By

  • Yaner Gu

  • Qiong Wang

  • Juan Fang

  • Jing Chen

  • Kaiting Hong

  • Zhanwei Zhang

  • Syed Shams Ul Hassan

  • Yin Chen

  • Xuqian Zhang

  • July 21, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology

  • #2

    Brigham and Women’s Hospital/Dana Farber Cancer Institute
    Brigham and Women’s Hospital/Dana Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology

  • #3

    University of California, San Francisco
    University of California, San Francisco

    San Francisco, CA

    Key Differentiators

    • Hematology

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology

  • #5

    St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital

    Memphis, TN

    Key Differentiators

    • Hematology

Original Source(s)

Non-anticoagulant heparins: glycan-mediated immune modulation and therapeutic applications

  • by Yaner Gu, Qiong Wang, Juan Fang, Jing Chen, Kaiting Hong, Zhanwei Zhang, Syed Shams Ul Hassan, Yin Chen, Xuqian Zhang

  • July 21, 2026

Related Content

Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eµ-TCL1 mice

An FDG-first functional imaging approach in phaeochromocytoma and paraganglioma

Prognostic significance of tumoral Siglec-15 expression in solid tumors: a systematic review and meta-analysis